Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 22.62 USD -1.61% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd

Wall Street analysts forecast KNSA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KNSA is 34.88 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.

Lowest
Price Target
30.3 USD
34% Upside
Average
Price Target
34.88 USD
54% Upside
Highest
Price Target
42 USD
86% Upside

KNSA Last Price Targets
Kiniksa Pharmaceuticals Ltd

The latest public price target was made on Oct 29, 2024 by Liisa Bayko from Evercore ISI , who expects KNSA stock to rise by 55% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Liisa Bayko
Evercore ISI
35 USD
Upside 55%
2 weeks ago
Oct 29, 2024
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
StreetInsider
Roger Song
Jefferies
40 USD
Upside 77%
2 months ago
Sep 13, 2024
Jefferies Starts Kiniksa (KNSA) at Buy
StreetInsider
Eva Fortea Verdejo
Wells Fargo
34 USD
Upside 50%
6 months ago
May 3, 2024
Wells Fargo Starts Kiniksa (KNSA) at Overweight, 'we see +15-25% upside potential'
StreetInsider
Liisa Bayko
Evercore ISI
Price Target 35 USD
Upside/Downside 55%
View Source
Roger Song
Jefferies
Price Target 40 USD
Upside/Downside 77%
View Source
Eva Fortea Verdejo
Wells Fargo
Price Target 34 USD
Upside/Downside 50%
View Source
Kiniksa Pharmaceuticals Ltd Competitors:
Price Targets
ALLO
Allogene Therapeutics Inc
260% Upside
ARWR
Arrowhead Pharmaceuticals Inc
123% Upside
BEAM
Beam Therapeutics Inc
80% Upside
ACLX
Arcellx Inc
7% Downside
VTGN
VistaGen Therapeutics Inc
370% Upside
2616
CStone Pharmaceuticals
41% Upside
BNTX
BioNTech SE
21% Upside
ARTV
Artiva Biotherapeutics Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Kiniksa Pharmaceuticals Ltd

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Kiniksa Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Kiniksa Pharmaceuticals Ltd

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is 55%.

N/A
Past Growth
55%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KNSA's stock price target?
Price Target
34.88 USD

According to Wall Street analysts, the average 1-year price target for KNSA is 34.88 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.

What is Kiniksa Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
37%

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is 37%.

What is Kiniksa Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
55%

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is 55%.

Back to Top